182 related articles for article (PubMed ID: 25748128)
1. [Revertant somatic mosaicism in primary immunodeficiency diseases].
Wada T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):447-53. PubMed ID: 25748128
[TBL] [Abstract][Full Text] [Related]
2. Somatic mosaicism in primary immune deficiencies.
Wada T; Candotti F
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):510-4. PubMed ID: 18978464
[TBL] [Abstract][Full Text] [Related]
3. Reversion Mosaicism in Primary Immunodeficiency Diseases.
Miyazawa H; Wada T
Front Immunol; 2021; 12():783022. PubMed ID: 34868061
[TBL] [Abstract][Full Text] [Related]
4. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
[TBL] [Abstract][Full Text] [Related]
5. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
[TBL] [Abstract][Full Text] [Related]
6. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
[TBL] [Abstract][Full Text] [Related]
7. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.
Davis BR; Candotti F
Immunol Res; 2009; 44(1-3):127-31. PubMed ID: 19129986
[TBL] [Abstract][Full Text] [Related]
8. Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.
Wada T; Schurman SH; Otsu M; Garabedian EK; Ochs HD; Nelson DL; Candotti F
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8697-702. PubMed ID: 11447283
[TBL] [Abstract][Full Text] [Related]
9. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.
Wada T; Schurman SH; Jagadeesh GJ; Garabedian EK; Nelson DL; Candotti F
Blood; 2004 Sep; 104(5):1270-2. PubMed ID: 15142877
[TBL] [Abstract][Full Text] [Related]
10. Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247.
Marin AV; Jiménez-Reinoso A; Briones AC; Muñoz-Ruiz M; Aydogmus C; Pasick LJ; Couso J; Mazariegos MS; Alvarez-Prado AF; Blázquez-Moreno A; Cipe FE; Haskologlu S; Dogu F; Morín M; Moreno-Pelayo MA; García-Sánchez F; Gil-Herrera J; Fernández-Malavé E; Reyburn HT; Ramiro AR; Ikinciogullari A; Recio MJ; Regueiro JR; Garcillán B
J Allergy Clin Immunol; 2017 Jan; 139(1):347-349.e8. PubMed ID: 27555457
[No Abstract] [Full Text] [Related]
11. Revertant mosaicism in the skin.
Lai-Cheong JE; McGrath JA
G Ital Dermatol Venereol; 2013 Feb; 148(1):73-82. PubMed ID: 23407079
[TBL] [Abstract][Full Text] [Related]
12. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
[TBL] [Abstract][Full Text] [Related]
13. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy.
Pasmooij AM; Jonkman MF; Uitto J
Discov Med; 2012 Sep; 14(76):167-79. PubMed ID: 23021371
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis and treatment of primary immunodeficiency disorders.
Smart BA; Ochs HD
Curr Opin Pediatr; 1997 Dec; 9(6):570-6. PubMed ID: 9425589
[TBL] [Abstract][Full Text] [Related]
15. In vivo reversion to normal of inherited mutations in humans.
Hirschhorn R
J Med Genet; 2003 Oct; 40(10):721-8. PubMed ID: 14569115
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function
Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
[TBL] [Abstract][Full Text] [Related]
17. Experiments of nature: primary immune defects deciphered and defeated.
Smith CI
Immunol Rev; 2000 Dec; 178():5-7. PubMed ID: 11213807
[No Abstract] [Full Text] [Related]
18. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.
Hirschhorn R; Yang DR; Puck JM; Huie ML; Jiang CK; Kurlandsky LE
Nat Genet; 1996 Jul; 13(3):290-5. PubMed ID: 8673127
[TBL] [Abstract][Full Text] [Related]
19. Progress in primary immunodeficiency.
Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
[TBL] [Abstract][Full Text] [Related]
20. Revertant somatic mosaicism as a cause of cancer.
Inaba T; Nagamachi A
Cancer Sci; 2021 Apr; 112(4):1383-1389. PubMed ID: 33583097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
